{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:04:55Z","timestamp":1774440295515,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005942","name":"Funda\u00e7\u00e3o Butantan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005942","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Estado de S\u00e3o Paulo","award":["2020\/10127-1"],"award-info":[{"award-number":["2020\/10127-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-37815-1","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:15:50Z","timestamp":1771503350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Indirect protection and long-term effectiveness of inactivated COVID-19 vaccine: a stepped-wedge randomised trial in Serrana, Brazil"],"prefix":"10.1038","volume":"16","author":[{"given":"Marcos Carvalho","family":"Borges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica Tilli Reis Pessoa","family":"Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Jardim","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha Nicos","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Manoel Marques","family":"Garibaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedito Antonio Lopes","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Tocantins","family":"Calado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara Marques","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Belmonte Martinelli","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassia Fernanda Sales","family":"de Lima Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenda Renata","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone Kashima","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erique Jose Farias Peixoto","family":"de Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia Emilia","family":"Braga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Ragiotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Italo Dias","family":"Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos Alves","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Bassolli","family":"de Oliveira Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"de Camargo Vieira Tenorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra Coccuzo","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimas Tadeu","family":"Covas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Aparecida Alves Leite","family":"dos Santos Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eolo","family":"Morandi Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Castro","family":"Boulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"10280","key":"37815_CR1","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/S0140-6736(21)00503-1","volume":"397","author":"N Lurie","year":"2021","unstructured":"Lurie, N., Keusch, G. T. & Dzau, V. J. Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development. Lancet 397 (10280), 1229\u20131236 (2021).","journal-title":"Lancet"},{"issue":"1","key":"37815_CR2","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1186\/s13063-020-04775-4","volume":"21","author":"R Palacios","year":"2020","unstructured":"Palacios, R. et al. Double-blind, randomized, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of treating healthcare professionals with the adsorbed COVID-19 (inactivated) vaccine manufactured by sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial. Trials 21 (1), 853 (2020).","journal-title":"Trials"},{"issue":"10296","key":"37815_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0140-6736(21)01429-X","volume":"398","author":"MD Tanriover","year":"2021","unstructured":"Tanriover, M. D. et al. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet 398 (10296), 213\u2013222 (2021).","journal-title":"Lancet"},{"issue":"27","key":"37815_CR4","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N. Engl. J. Med. 383 (27), 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"37815_CR5","unstructured":"Control ECfDPa. Efficacy, effectiveness and safety of EU\/EEA-authorised vaccines against COVID-19: living systematic review 2024. https:\/\/covid19-vaccines-efficacy.ecdc.europa.eu\/."},{"issue":"10","key":"37815_CR6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa2107715","volume":"385","author":"A Jara","year":"2021","unstructured":"Jara, A. et al. Effectiveness of an Inactivated SARS-CoV-2 vaccine in Chile. N. Engl. J. Med. 385 (10), 875\u2013884 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"37815_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1139\/cjm-2020-0465","volume":"67","author":"RL Russell","year":"2021","unstructured":"Russell, R. L., Pelka, P. & Mark, B. L. Frontrunners in the race to develop a SARS-CoV-2 vaccine. Can. J. Microbiol. 67 (3), 189\u2013212 (2021).","journal-title":"Can. J. Microbiol."},{"issue":"2","key":"37815_CR8","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/S1473-3099(20)30773-8","volume":"21","author":"SH Hodgson","year":"2021","unstructured":"Hodgson, S. H. et al. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect. Dis. 21 (2), e26\u2013e35 (2021).","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"37815_CR9","doi-asserted-by":"publisher","first-page":"e0261930","DOI":"10.1371\/journal.pone.0261930","volume":"17","author":"Y Teerawattananon","year":"2022","unstructured":"Teerawattananon, Y. et al. A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings. PLoS ONE 17 (1), e0261930 (2022).","journal-title":"PLoS ONE"},{"issue":"1","key":"37815_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12916-023-02861-3","volume":"21","author":"S Xu","year":"2023","unstructured":"Xu, S. et al. Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis. BMC Med. 21 (1), 160 (2023).","journal-title":"BMC Med."},{"issue":"21","key":"37815_CR11","first-page":"5782","volume":"47","author":"The Gambia Hepatitis Intervention Study","year":"1987","unstructured":"The Gambia Hepatitis Intervention Study. The gambia hepatitis study group. Cancer Res. 47 (21), 5782\u20135787 (1987).","journal-title":"Cancer Res."},{"issue":"6","key":"37815_CR12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S1473-3099(15)70139-8","volume":"15","author":"SE Bellan","year":"2015","unstructured":"Bellan, S. E. et al. Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. Lancet Infect. Dis. 15 (6), 703\u2013710 (2015).","journal-title":"Lancet Infect. Dis."},{"issue":"12","key":"37815_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/medethics-2015-103292","volume":"42","author":"A Doussau","year":"2016","unstructured":"Doussau, A. & Grady, C. Deciphering assumptions about stepped wedge designs: the case of Ebola vaccine research. J. Med. Ethics 42 (12), 797\u2013804 (2016).","journal-title":"J. Med. Ethics"},{"key":"37815_CR14","doi-asserted-by":"publisher","first-page":"h391","DOI":"10.1136\/bmj.h391","volume":"350","author":"K Hemming","year":"2015","unstructured":"Hemming, K., Haines, T. P., Chilton, P. J., Girling, A. J. & Lilford, R. J. The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting. BMJ 350, h391 (2015).","journal-title":"BMJ"},{"key":"37815_CR15","first-page":"9","volume":"12","author":"J Mascarenhas","year":"1991","unstructured":"Mascarenhas, J. & Kumar, P. D. P. Participatory mapping and modelling users\u2019 notes. PLA Notes 12, 9\u201320 (1991).","journal-title":"PLA Notes"},{"key":"37815_CR16","doi-asserted-by":"publisher","first-page":"100301","DOI":"10.1016\/j.puhip.2022.100301","volume":"4","author":"NN Ferreira","year":"2022","unstructured":"Ferreira, N. N. et al. The impact of an enhanced health surveillance system for COVID-19 management in Serrana, Brazil. Public Health Pract. (Oxf.) 4, 100301 (2022).","journal-title":"Public Health Pract. (Oxf.)"},{"issue":"1","key":"37815_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/oxfordjournals.epirev.a017990","volume":"21","author":"ME Halloran","year":"1999","unstructured":"Halloran, M. E., Longini, I. M. Jr. & Struchiner, C. J. Design and interpretation of vaccine field studies. Epidemiol. Rev. 21 (1), 73\u201388 (1999).","journal-title":"Epidemiol. Rev."},{"issue":"1","key":"37815_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12916-017-0911-8","volume":"15","author":"A Wilder-Smith","year":"2017","unstructured":"Wilder-Smith, A. et al. The public health value of vaccines beyond efficacy: methods, measures and outcomes. BMC Med. 15 (1), 138 (2017).","journal-title":"BMC Med."},{"issue":"7","key":"37815_CR19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/aje\/kwu001","volume":"179","author":"CA Panozzo","year":"2014","unstructured":"Panozzo, C. A. et al. Direct, indirect, total, and overall effectiveness of the rotavirus vaccines for the prevention of gastroenteritis hospitalizations in privately insured US children, 2007\u20132010. Am J Epidemiol. 179 (7), 895\u2013909 (2014).","journal-title":"Am J Epidemiol."},{"issue":"5","key":"37815_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S2213-2600(23)00015-2","volume":"11","author":"N Wu","year":"2023","unstructured":"Wu, N. et al. Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. Lancet Respir. Med. 11 (5), 439\u2013452 (2023).","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"37815_CR21","doi-asserted-by":"publisher","first-page":"e2517402","DOI":"10.1001\/jamanetworkopen.2025.17402","volume":"8","author":"R Link-Gelles","year":"2025","unstructured":"Link-Gelles, R. et al. Estimated 2023\u20132024 COVID-19 vaccine effectiveness in adults. JAMA Netw. Open 8 (6), e2517402 (2025).","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"37815_CR22","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.1038\/s41467-022-33169-0","volume":"13","author":"OT Ranzani","year":"2022","unstructured":"Ranzani, O. T. et al. Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil. Nat. Commun. 13 (1), 5536 (2022).","journal-title":"Nat. Commun."},{"issue":"7","key":"37815_CR23","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1473-3099(23)00058-0","volume":"23","author":"H Chemaitelly","year":"2023","unstructured":"Chemaitelly, H. et al. Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study. Lancet Infect. Dis. 23 (7), 816\u2013827 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"37815_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijid.2023.03.022","volume":"131","author":"K Bodner","year":"2023","unstructured":"Bodner, K., Irvine, M. A., Kwong, J. C. & Mishra, S. Observed negative vaccine effectiveness could be the canary in the coal mine for biases in observational COVID-19 studies. Int. J. Infect. Dis. 131, 111\u2013114 (2023).","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"37815_CR25","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1038\/s41467-022-31838-8","volume":"13","author":"SP Andeweg","year":"2022","unstructured":"Andeweg, S. P. et al. Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections. Nat. Commun. 13 (1), 4738 (2022).","journal-title":"Nat. Commun."},{"issue":"16","key":"37815_CR26","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","volume":"386","author":"N Andrews","year":"2022","unstructured":"Andrews, N. et al. Covid-19 vaccine effectiveness against the Omicron (B11529) variant. N. Engl. J. Med. 386 (16), 1532\u20131546 (2022).","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"37815_CR27","doi-asserted-by":"publisher","first-page":"e2232760","DOI":"10.1001\/jamanetworkopen.2022.32760","volume":"5","author":"SA Buchan","year":"2022","unstructured":"Buchan, S. A. et al. Estimated effectiveness of COVID-19 Vaccines against Omicron or delta symptomatic infection and severe outcomes. JAMA Netw. Open 5 (9), e2232760 (2022).","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"37815_CR28","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1038\/s41467-022-31839-7","volume":"13","author":"T Cerqueira-Silva","year":"2022","unstructured":"Cerqueira-Silva, T. et al. Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil. Nat. Commun. 13 (1), 4154 (2022).","journal-title":"Nat. Commun."},{"issue":"1","key":"37815_CR29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41467-022-35727-y","volume":"14","author":"ZY Huang","year":"2023","unstructured":"Huang, Z. Y. et al. Effectiveness of inactivated COVID-19 vaccines among older adults in Shanghai: retrospective cohort study. Nat. Commun. 14 (1), 77 (2023).","journal-title":"Nat. Commun."},{"issue":"1","key":"37815_CR30","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s12916-022-02606-8","volume":"20","author":"ZY Huang","year":"2022","unstructured":"Huang, Z. Y. et al. Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death. Bmc Med. 20 (1), 400 (2022).","journal-title":"Bmc Med."},{"issue":"10","key":"37815_CR31","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/S1473-3099(22)00345-0","volume":"22","author":"ME McMenamin","year":"2022","unstructured":"McMenamin, M. E. et al. Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study. Lancet Infect. Dis. 22 (10), 1435\u20131443 (2022).","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"37815_CR32","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12879-017-2399-4","volume":"17","author":"M Eichner","year":"2017","unstructured":"Eichner, M., Schwehm, M., Eichner, L. & Gerlier, L. Direct and indirect effects of influenza vaccination. BMC Infect. Dis. 17 (1), 308 (2017).","journal-title":"BMC Infect. Dis."},{"issue":"6","key":"37815_CR33","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1016\/j.jinf.2020.03.027","volume":"80","author":"KO Kwok","year":"2020","unstructured":"Kwok, K. O., Lai, F., Wei, W. I., Wong, S. Y. S. & Tang, J. W. T. Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries. J. Infect. 80 (6), e32\u2013e33 (2020).","journal-title":"J. Infect."},{"issue":"6","key":"37815_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41577-022-00725-0","volume":"22","author":"D Goldblatt","year":"2022","unstructured":"Goldblatt, D. SARS-CoV-2: from herd immunity to hybrid immunity. Nat. Rev. Immunol. 22 (6), 333\u2013334 (2022).","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"37815_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.25100\/cm.v49i3.4154","volume":"49","author":"R Palacios","year":"2018","unstructured":"Palacios, R. Forgotten, but not forgiven: facing immunization challenges in the 21 (st) century. Colomb. Med. (Cali). 49 (3), 189\u2013192 (2018).","journal-title":"Colomb. Med. (Cali)."},{"issue":"11","key":"37815_CR36","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1093\/aje\/kwaa141","volume":"189","author":"L Kennedy-Shaffer","year":"2020","unstructured":"Kennedy-Shaffer, L. & Lipsitch, M. Statistical properties of stepped wedge cluster-randomized trials in infectious disease outbreaks. Am. J. Epidemiol. 189 (11), 1324\u20131332 (2020).","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"37815_CR37","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/ije\/dyaa077","volume":"49","author":"K Hemming","year":"2020","unstructured":"Hemming, K. & Taljaard, M. Reflection on modern methods: when is a stepped-wedge cluster randomized trial a good study design choice?. Int. J. Epidemiol. 49 (3), 1043\u20131052 (2020).","journal-title":"Int. J. Epidemiol."},{"key":"37815_CR38","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ijregi.2023.04.003","volume":"7","author":"GJ Volpe","year":"2023","unstructured":"Volpe, G. J. et al. Antibody response dynamics to CoronaVac vaccine and booster immunization in adults and the elderly: A long-term, longitudinal prospective study. IJID Reg. 7, 222\u2013229 (2023).","journal-title":"IJID Reg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37815-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37815-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37815-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T08:48:15Z","timestamp":1774428495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37815-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37815"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37815-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MCB, BMC, BBMG, CFSLD, GJV, NNF, PMMG, BALF, and RTC received research funding from Butantan Institute during the conduct of this study. RP, MTRPC, and DTC were employees of Butantan Institute during the conduct of this study. EJFP, PEB, LR, JIDF, MAL, LBOA, JCVT, SCSV, DTC, MAALSA, EMJ, and FCB are employees of Butantan Institute. All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was reviewed and approved by the Ethics Committee of the Clinical Hospital, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo (CAAE 42390621.1.0000.5440). All procedures were conducted in accordance with the ethical standards of the institutional committee on human experimentation and with the Declaration of Helsinki, as revised in 1975 and subsequently amended. Informed consent was obtained from all participants and\/or their legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"9879"}}